DE4112440C1 - - Google Patents
Info
- Publication number
- DE4112440C1 DE4112440C1 DE4112440A DE4112440A DE4112440C1 DE 4112440 C1 DE4112440 C1 DE 4112440C1 DE 4112440 A DE4112440 A DE 4112440A DE 4112440 A DE4112440 A DE 4112440A DE 4112440 C1 DE4112440 C1 DE 4112440C1
- Authority
- DE
- Germany
- Prior art keywords
- selection
- nucleic acid
- mutagenesis
- cycle
- acid sequences
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 claims abstract description 34
- 231100000350 mutagenesis Toxicity 0.000 claims abstract description 24
- 238000002703 mutagenesis Methods 0.000 claims abstract description 24
- 238000009826 distribution Methods 0.000 claims abstract description 23
- 150000007523 nucleic acids Chemical group 0.000 claims abstract description 22
- 239000000203 mixture Substances 0.000 claims abstract description 15
- 229920001222 biopolymer Polymers 0.000 claims abstract description 10
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 7
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 7
- 238000013519 translation Methods 0.000 claims abstract description 6
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 5
- 230000035772 mutation Effects 0.000 claims description 17
- 238000005457 optimization Methods 0.000 claims description 15
- 238000006243 chemical reaction Methods 0.000 claims description 11
- 230000010076 replication Effects 0.000 claims description 10
- 230000008569 process Effects 0.000 claims description 8
- 238000001228 spectrum Methods 0.000 claims description 8
- 230000003321 amplification Effects 0.000 claims description 5
- 238000013459 approach Methods 0.000 claims description 5
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 5
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 claims description 4
- 210000002729 polyribosome Anatomy 0.000 claims description 4
- 230000008878 coupling Effects 0.000 claims description 3
- 238000010168 coupling process Methods 0.000 claims description 3
- 238000005859 coupling reaction Methods 0.000 claims description 3
- 230000008827 biological function Effects 0.000 claims description 2
- 239000002213 purine nucleotide Substances 0.000 claims description 2
- 239000002719 pyrimidine nucleotide Substances 0.000 claims description 2
- 150000003230 pyrimidines Chemical class 0.000 claims description 2
- 230000005855 radiation Effects 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 230000000052 comparative effect Effects 0.000 claims 1
- 239000003471 mutagenic agent Substances 0.000 claims 1
- 231100000707 mutagenic chemical Toxicity 0.000 claims 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 230000014616 translation Effects 0.000 description 4
- 239000002253 acid Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 238000009434 installation Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 210000004940 nucleus Anatomy 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 230000004544 DNA amplification Effects 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 238000010187 selection method Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 206010069754 Acquired gene mutation Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 206010010219 Compulsions Diseases 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 241000009298 Trigla lyra Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 238000005094 computer simulation Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000010429 evolutionary process Effects 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 108010026228 mRNA guanylyltransferase Proteins 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 230000037439 somatic mutation Effects 0.000 description 1
- 230000008080 stochastic effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000005496 tempering Methods 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1058—Directional evolution of libraries, e.g. evolution of libraries is achieved by mutagenesis and screening or selection of mixed population of organisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1079—Screening libraries by altering the phenotype or phenotypic trait of the host
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Ecology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4112440A DE4112440C1 (cg-RX-API-DMAC10.html) | 1991-04-16 | 1991-04-16 | |
| DE59209506T DE59209506D1 (de) | 1991-04-16 | 1992-04-14 | Verfahren zur herstellung von neuen biopolymeren |
| AT92908537T ATE171479T1 (de) | 1991-04-16 | 1992-04-14 | Verfahren zur herstellung von neuen biopolymeren |
| JP50798892A JP3504658B2 (ja) | 1991-04-16 | 1992-04-14 | 新規生体高分子の製造方法 |
| EP92908537A EP0583265B1 (de) | 1991-04-16 | 1992-04-14 | Verfahren zur herstellung von neuen biopolymeren |
| PCT/EP1992/000840 WO1992018645A1 (de) | 1991-04-16 | 1992-04-14 | Verfahren zur herstellung von neuen biopolymeren |
| US08/507,190 US5795747A (en) | 1991-04-16 | 1995-06-26 | Process for manufacturing new biopolymers |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4112440A DE4112440C1 (cg-RX-API-DMAC10.html) | 1991-04-16 | 1991-04-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE4112440C1 true DE4112440C1 (cg-RX-API-DMAC10.html) | 1992-10-22 |
Family
ID=6429722
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE4112440A Expired - Lifetime DE4112440C1 (cg-RX-API-DMAC10.html) | 1991-04-16 | 1991-04-16 | |
| DE59209506T Expired - Lifetime DE59209506D1 (de) | 1991-04-16 | 1992-04-14 | Verfahren zur herstellung von neuen biopolymeren |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE59209506T Expired - Lifetime DE59209506D1 (de) | 1991-04-16 | 1992-04-14 | Verfahren zur herstellung von neuen biopolymeren |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0583265B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP3504658B2 (cg-RX-API-DMAC10.html) |
| AT (1) | ATE171479T1 (cg-RX-API-DMAC10.html) |
| DE (2) | DE4112440C1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO1992018645A1 (cg-RX-API-DMAC10.html) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994010572A1 (de) * | 1992-11-05 | 1994-05-11 | Evotec Biosystems Gmbh | Trägermaterial zur simultanen bindung genotypischer und phänotypischer substanzen |
| US7235386B2 (en) | 2001-02-02 | 2007-06-26 | Large Scale Biology Corporation | Method of increasing complementarity in a heteroduplex |
| US7273739B2 (en) | 2002-02-01 | 2007-09-25 | Padgett Hal S | Nucleic acid molecules encoding endonucleases and methods of use thereof |
| US7582423B2 (en) | 2001-02-02 | 2009-09-01 | Novici Biotech Llc | Population of polynucleotide sequence variants |
| US7838219B2 (en) | 2001-02-02 | 2010-11-23 | Novici Biotech Llc | Method of increasing complementarity in a heteroduplex |
Families Citing this family (82)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5849545A (en) * | 1992-05-11 | 1998-12-15 | Evotec Biosystems Gmbh | Substrate material for simultaneously binding genotypic and phenotypic substances |
| DE4343591A1 (de) * | 1993-12-21 | 1995-06-22 | Evotec Biosystems Gmbh | Verfahren zum evolutiven Design und Synthese funktionaler Polymere auf der Basis von Formenelementen und Formencodes |
| US6309883B1 (en) | 1994-02-17 | 2001-10-30 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
| US5605793A (en) * | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| US6117679A (en) | 1994-02-17 | 2000-09-12 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| US6995017B1 (en) | 1994-02-17 | 2006-02-07 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| US6165793A (en) * | 1996-03-25 | 2000-12-26 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| US6335160B1 (en) | 1995-02-17 | 2002-01-01 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
| US5837458A (en) | 1994-02-17 | 1998-11-17 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
| WO1996017056A1 (en) * | 1994-12-02 | 1996-06-06 | Institut Pasteur | Hypermutagenesis |
| EP0714980A1 (en) * | 1994-12-02 | 1996-06-05 | Institut Pasteur | Hypermutagenesis |
| US6936289B2 (en) | 1995-06-07 | 2005-08-30 | Danisco A/S | Method of improving the properties of a flour dough, a flour dough improving composition and improved food products |
| JPH1066577A (ja) * | 1996-08-07 | 1998-03-10 | Novo Nordisk As | 核酸プールおよびその製造方法 |
| US6261804B1 (en) | 1997-01-21 | 2001-07-17 | The General Hospital Corporation | Selection of proteins using RNA-protein fusions |
| US8207093B2 (en) | 1997-01-21 | 2012-06-26 | The General Hospital Corporation | Selection of proteins using RNA-protein fusions |
| ATE332368T1 (de) | 1997-01-21 | 2006-07-15 | Gen Hospital Corp | Selektion von proteinen mittels rns-protein fusionen |
| US6153410A (en) * | 1997-03-25 | 2000-11-28 | California Institute Of Technology | Recombination of polynucleotide sequences using random or defined primers |
| ES2168236T3 (es) | 1997-04-09 | 2005-04-16 | Danisco A/S | Utilizacion de lipasa para mejorar las pastas de pan y los productos de panaderia. |
| CA2302147C (en) * | 1997-09-03 | 2008-05-13 | Biovation Limited | Methods for protein screening |
| AU754377B2 (en) * | 1997-09-03 | 2002-11-14 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Methods for protein screening |
| US6927025B1 (en) | 1997-09-03 | 2005-08-09 | Biovation Limited | Methods for protein screening |
| EP1036198B1 (en) | 1997-12-08 | 2012-09-26 | California Institute Of Technology | Method for creating polynucleotide and polypeptide sequences |
| US7153655B2 (en) | 1998-06-16 | 2006-12-26 | Alligator Bioscience Ab | Method for in vitro molecular evolution of protein function involving the use of exonuclease enzyme and two populations of parent polynucleotide sequence |
| JP2002517995A (ja) * | 1998-06-17 | 2002-06-25 | マキシジェン， インコーポレイテッド | 所望の特性を有するポリヌクレオチドを生成するための方法 |
| US6846655B1 (en) | 1998-06-29 | 2005-01-25 | Phylos, Inc. | Methods for generating highly diverse libraries |
| ES2188190T5 (es) | 1998-07-21 | 2007-11-16 | Danisco A/S | Producto alimentario. |
| WO2000009464A1 (en) | 1998-08-17 | 2000-02-24 | Phylos, Inc. | Identification of compound-protein interactions using libraries of protein-nucleic acid fusion molecules |
| DE19953854C2 (de) | 1999-11-09 | 2002-01-17 | Max Planck Gesellschaft | Verfahren zur Herstellung von Biopolymeren mit veränderten Eigenschaften |
| US7022479B2 (en) | 2000-01-24 | 2006-04-04 | Compound Therapeutics, Inc. | Sensitive, multiplexed diagnostic assays for protein analysis |
| DE60118527D1 (de) | 2000-01-24 | 2006-05-18 | Compound Therapeutics Inc | Sensible und multiplexe diagnostische tests zur proteinanalyse |
| US6958213B2 (en) | 2000-12-12 | 2005-10-25 | Alligator Bioscience Ab | Method for in vitro molecular evolution of protein function |
| US20020086292A1 (en) | 2000-12-22 | 2002-07-04 | Shigeaki Harayama | Synthesis of hybrid polynucleotide molecules using single-stranded polynucleotide molecules |
| DK1387616T3 (da) | 2001-05-18 | 2007-09-24 | Danisco | Fremgangsmåde til fremstilling af en dej med et enzym |
| EP1840211A1 (en) | 2001-10-31 | 2007-10-03 | Danisco A/S | Pyranosone dehydratase from phanerochaete chrysosporium |
| DE60312507T3 (de) | 2002-05-17 | 2011-08-18 | Alligator Bioscience Ab | Eine methode zur in vitro molekularen evolution der proteinfunktion |
| JP2005539093A (ja) * | 2002-07-17 | 2005-12-22 | ユニリーバー・ナームローゼ・ベンノートシヤープ | 分枝状アルコールのカルボキシアルキレート及び／またはそのアルコキシレートを含有するスキンケア用化粧組成物 |
| DE602004030000D1 (de) | 2003-01-17 | 2010-12-23 | Danisco | Verfahren zur in-situ-herstellung eines emulgators in einem nahrungsmittel |
| US7955814B2 (en) | 2003-01-17 | 2011-06-07 | Danisco A/S | Method |
| CA2512734C (en) | 2003-01-17 | 2012-06-19 | Danisco A/S | Method of producing one or more of a carbohydrate ester, a protein ester, a protein subunit ester and a hydroxy acid ester |
| US20050196766A1 (en) | 2003-12-24 | 2005-09-08 | Soe Jorn B. | Proteins |
| CA2529659A1 (en) | 2003-06-18 | 2004-12-29 | Ulrich Haupts | Engineered proteolytic enzyme with altered specificity determining regions |
| GB0716126D0 (en) | 2007-08-17 | 2007-09-26 | Danisco | Process |
| WO2005066347A1 (en) | 2003-12-24 | 2005-07-21 | Danisco A/S | Proteins |
| US7718408B2 (en) | 2003-12-24 | 2010-05-18 | Danisco A/S | Method |
| GB0405637D0 (en) | 2004-03-12 | 2004-04-21 | Danisco | Protein |
| DK1776455T3 (da) | 2004-07-16 | 2015-06-22 | Dupont Nutrition Biosci Aps | Lipolytisk enzym, anvendelser deraf i fødevareindustrien |
| GB0421598D0 (en) | 2004-09-29 | 2004-10-27 | Cambridge Advanced Tech | Modification of plant development and morphology |
| GB0422052D0 (en) | 2004-10-04 | 2004-11-03 | Dansico As | Enzymes |
| GB0423139D0 (en) | 2004-10-18 | 2004-11-17 | Danisco | Enzymes |
| US8846366B2 (en) | 2006-12-14 | 2014-09-30 | Dsm Ip Assets Bv | R-hydroxynitrile lyase (R-HNL) random variants and their use for preparing optically pure, sterically hindered cyanohydrins |
| EP2405007B1 (en) | 2007-01-25 | 2013-12-04 | DuPont Nutrition Biosciences ApS | Production of a lipid acyltransferase from transformed Bacillus licheniformis cells |
| US8143046B2 (en) | 2007-02-07 | 2012-03-27 | Danisco Us Inc., Genencor Division | Variant Buttiauxella sp. phytases having altered properties |
| US20080220498A1 (en) | 2007-03-06 | 2008-09-11 | Cervin Marguerite A | Variant Buttiauxella sp. phytases having altered properties |
| DK2147104T3 (en) | 2007-05-21 | 2015-12-14 | Danisco Us Inc | USING A ASPARAGINPROTEASE- (NSP24) SIGNAL SEQUENCE FOR heterologous protein EXPRESSION |
| DK2283124T3 (en) | 2008-04-18 | 2016-09-05 | Danisco Us Inc | BUTTIAUXELLA SP. PHYTASE VARIANTS |
| EP2279248B1 (en) | 2008-04-30 | 2015-04-01 | DuPont Nutrition Biosciences ApS | Proteins |
| GB0908770D0 (en) | 2009-04-24 | 2009-07-01 | Danisco | Method |
| CA2761767A1 (en) | 2009-05-19 | 2010-11-25 | Danisco A/S | Use of amylase and lipolytic enzyme in bread |
| AR077042A1 (es) | 2009-06-12 | 2011-07-27 | Danisco | Metodo para tratar una composicion que contiene pirofiofitina |
| GB0920089D0 (en) | 2009-11-17 | 2009-12-30 | Danisco | Method |
| US9040277B2 (en) | 2010-01-13 | 2015-05-26 | Basf Se | Mannanase variants |
| AR080293A1 (es) | 2010-03-12 | 2012-03-28 | Danisco | Proceso de refinamiento de un aceite vegetal |
| WO2011114251A1 (en) | 2010-03-18 | 2011-09-22 | Danisco A/S | Foodstuff |
| EP2582809A1 (en) | 2010-06-17 | 2013-04-24 | DuPont Nutrition Biosciences ApS | Process |
| GB201011513D0 (en) | 2010-07-08 | 2010-08-25 | Danisco | Method |
| WO2012114232A1 (en) | 2011-02-23 | 2012-08-30 | Dupont Nutrition Biosciences Aps | Process |
| WO2012114231A2 (en) | 2011-02-23 | 2012-08-30 | Dupont Nutrition Biosciences Aps | Method |
| CN107156333A (zh) | 2011-02-23 | 2017-09-15 | 杜邦营养生物科学有限公司 | 植物油的加工方法 |
| MX2013011617A (es) | 2011-04-08 | 2013-11-21 | Danisco Us Inc | Composiciones. |
| RS57397B8 (sr) | 2011-06-10 | 2020-01-31 | Univ Oregon Health & Science | Cmv glikoproteini i rekombinantni vektori |
| WO2013104659A2 (en) | 2012-01-13 | 2013-07-18 | Dupont Nutrition Biosciences Aps | Process |
| WO2013104660A1 (en) | 2012-01-13 | 2013-07-18 | Dupont Nutrition Biosciences Aps | Process for treating a plant oil comprising hydrolysing chlorophyll or a chlorophyll derivative and involving partial caustic neutralisation |
| WO2013160374A1 (en) | 2012-04-27 | 2013-10-31 | Dupont Nutrition Biosciences Aps | Process for refining crude plant oil involving enzymatic hydrolysis and gum recycling |
| WO2013160372A1 (en) | 2012-04-27 | 2013-10-31 | Dupont Nutrition Biosciences Aps | Process for treating plant oil involving addition of serial doses of chlorophyll or chlorophyll derivative degrading enzyme |
| EP2909230B1 (en) | 2012-10-19 | 2019-05-22 | Danisco US Inc. | Stabilization of biomimetic membranes |
| CA2934039A1 (en) | 2013-12-19 | 2015-06-25 | Danisco Us Inc. | Use of hydrophobins to increase gas transferin aerobic fermentation processes |
| US20170121741A1 (en) | 2014-04-01 | 2017-05-04 | Dupont Nutrition Biosciences Aps | Method for increasing crude palm oil yields |
| WO2016065238A1 (en) | 2014-10-24 | 2016-04-28 | Danisco Us Inc. | Method for producing alcohol by use of a tripeptidyl peptidase |
| US20170325479A1 (en) | 2014-10-24 | 2017-11-16 | Dupont Nutrition Biosciences Aps | Proline tolerant tripeptidyl peptidases and uses thereof |
| BR112017028035A2 (pt) | 2015-06-26 | 2018-08-28 | Dupont Nutrition Biosci Aps | aminopeptidases para hidrolisados de proteína |
| US20210120845A1 (en) | 2016-02-25 | 2021-04-29 | Dupont Nutrition Biosciences Aps | Method for producing a protein hydrolysate employing an aspergillus fumigatus tripeptidyl peptidase |
| DE102023001827A1 (de) | 2023-04-19 | 2024-10-24 | Horst Wochnowski | Verfahren und dazugehörige Vorrichtung zum Züchten von in Gewässern Mikroplastik zersetzenden und abbauenden Mikroorganismenstämme durch einen künstlich herbeigeführten und beschleunigten Evolutions- und Selektionsprozess |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0285123A3 (en) * | 1987-04-03 | 1989-02-01 | Stabra AG | A method for complete mutagenesis of nucleic acids |
| WO1991005058A1 (en) * | 1989-10-05 | 1991-04-18 | Glenn Kawasaki | Cell-free synthesis and isolation of novel genes and polypeptides |
| WO1992002536A1 (en) * | 1990-08-02 | 1992-02-20 | The Regents Of The University Of Colorado | Systematic polypeptide evolution by reverse translation |
-
1991
- 1991-04-16 DE DE4112440A patent/DE4112440C1/de not_active Expired - Lifetime
-
1992
- 1992-04-14 DE DE59209506T patent/DE59209506D1/de not_active Expired - Lifetime
- 1992-04-14 EP EP92908537A patent/EP0583265B1/de not_active Expired - Lifetime
- 1992-04-14 WO PCT/EP1992/000840 patent/WO1992018645A1/de not_active Ceased
- 1992-04-14 AT AT92908537T patent/ATE171479T1/de not_active IP Right Cessation
- 1992-04-14 JP JP50798892A patent/JP3504658B2/ja not_active Expired - Lifetime
Non-Patent Citations (1)
| Title |
|---|
| NICHTS ERMITTELT * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994010572A1 (de) * | 1992-11-05 | 1994-05-11 | Evotec Biosystems Gmbh | Trägermaterial zur simultanen bindung genotypischer und phänotypischer substanzen |
| US7235386B2 (en) | 2001-02-02 | 2007-06-26 | Large Scale Biology Corporation | Method of increasing complementarity in a heteroduplex |
| US7582423B2 (en) | 2001-02-02 | 2009-09-01 | Novici Biotech Llc | Population of polynucleotide sequence variants |
| US7833759B2 (en) | 2001-02-02 | 2010-11-16 | Novici Biotech Llc | Method of increasing complementarity in a heteroduplex |
| US7838219B2 (en) | 2001-02-02 | 2010-11-23 | Novici Biotech Llc | Method of increasing complementarity in a heteroduplex |
| US7273739B2 (en) | 2002-02-01 | 2007-09-25 | Padgett Hal S | Nucleic acid molecules encoding endonucleases and methods of use thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| ATE171479T1 (de) | 1998-10-15 |
| DE59209506D1 (de) | 1998-10-29 |
| EP0583265A1 (de) | 1994-02-23 |
| EP0583265B1 (de) | 1998-09-23 |
| JPH06506355A (ja) | 1994-07-21 |
| WO1992018645A1 (de) | 1992-10-29 |
| JP3504658B2 (ja) | 2004-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE4112440C1 (cg-RX-API-DMAC10.html) | ||
| EP2175021B1 (de) | Verfahren zur Herstellung von Polymeren | |
| EP1181395B1 (de) | Verfahren zur synthese von dna-fragmenten | |
| DE60126786T2 (de) | Verfahren zur ortspezifischen massenmutagenese | |
| DE69636721T2 (de) | Screeningverfahren für enzyme und enzymkits | |
| DE69734063T2 (de) | Herstellung und verwendung von normalisierten dna-bibliotheken | |
| DE3855064T2 (de) | Selektive Amplifikation von Oligonukleotiden-Zielsequenzen | |
| DE69824004T2 (de) | Verfahren zur quantitativen bestimmung der genexpression mit hilfe der multiplexen competitiven reversen-transkriptase polymerase kettenreaktion | |
| DE69835360T2 (de) | EVOLUTION Prokaryotischer GANZER ZELLEN DURCH REKURSIVE SEQUENZREKOMBINATION | |
| DE69918820T2 (de) | Dna hochdurchsatzvektor für sequenzierung | |
| DE60028768T2 (de) | Verwendung des kammverfahrens zur identifizierung von dna replikationsstarts | |
| DE69631787T2 (de) | Verfahren zum screening enzymatischer aktivität | |
| WO2005030957A1 (de) | Verfahren zur in vitro evolution von polypeptiden | |
| EP2861339A1 (de) | Analyseverfahren auf basis eines arrays | |
| DE69737327T2 (de) | Verfahren zur identifizierung von essentiellen genen für das wachstum eines organismus | |
| DE60202196T2 (de) | Orientationsgerichtete konstruktion von plasmiden | |
| DE60115622T2 (de) | Methoden und zusammensetzungen zur aufklärung von proteinexpressionsprofilen in zellen | |
| DE60133556T2 (de) | Verbesserte kombinatorische genbanken durch rekombination in hefe und analyseverfahren | |
| DE10350474B4 (de) | Verfahren zur Selektion von Biomolekülen aus Varianten-Bibliotheken von Biomolekülen | |
| DE19957116A1 (de) | Verfahren zur Herstellung synthetischer Nukleinsäuredoppelstränge | |
| DE60034953T2 (de) | Genklonierung | |
| DE10232507C1 (de) | Verfahren zum sequenzkontrollierten Herstellen eines Nukleinsäureprodukts | |
| EP1266027A2 (de) | Dynamische sequenzierung durch hybridisierung | |
| DE60106749T2 (de) | Verfahren zum screening von mikroorganismen unter nährstofflimitierten bedingungen | |
| EP2365868B1 (de) | Elektro-ultrafiltrationsverfahren zur bestimmung der löslichkeit und mobilität von schwermetallen und/oder schadstoffen für abfall- und altlastenmaterialen sowie schwermetall- und/oder schadstoff kontaminierte böden |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8100 | Publication of patent without earlier publication of application | ||
| D1 | Grant (no unexamined application published) patent law 81 | ||
| 8364 | No opposition during term of opposition | ||
| 8327 | Change in the person/name/address of the patent owner |
Owner name: EVOTEC BIOSYSTEMS GMBH, 22529 HAMBURG, DE |
|
| 8327 | Change in the person/name/address of the patent owner |
Owner name: EVOTEC BIOSYSTEMS AG, 22525 HAMBURG, DE |
|
| 8327 | Change in the person/name/address of the patent owner |
Owner name: EVOTEC OAI AG, 22525 HAMBURG, DE |
|
| 8327 | Change in the person/name/address of the patent owner |
Owner name: DIREVO BIOTECH, 50829 KOELN, DE |
|
| R071 | Expiry of right |